Ovid Therapeutics Inc. OVID 深 滬
已收盤 09-19 16:00:00 美东时间
1.17
+0.110
+10.38%
華盛通- 最 高1.17
- 今 開1.11
- 成交量 11.31万股
- 最 低 1.0641
- 昨 收 1.06
- 總市值 8260.53万
- 52周最高 4.10
- 市盈率 靜 --
- 換手率 0.16%
- 52周最低 0.68
- 委 比 -88.23%
- 總股本 7060.28万
- 歷史最高 15.89
- 量 比 0.80
- 振 幅 9.99%
- 歷史最低 0.68
- 每 手 1
- 風險率 1.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Expert Outlook: Ovid Therapeutics Through The Eyes Of 7 Analysts
Providing a diverse range of perspectives from bullish to bearish, 7 analysts h...
08-19 20:00
纳斯达克生物科技指数收跌0.48%
成分股Humacyte也跌9.62%，Lyell Immunopharma跌12.41%，RAPT Therapeutics跌13.36%，ACELYRIN跌...
08-15 05:13
Wedbush Remains a Buy on Ovid Therapeutics (OVID)
In a report released today, Laura Chico from Wedbush maintained a Buy rating on...
08-14 20:16
BRINKER INTERNATIONAL REPORTS FOURTH QUARTER OF FISCAL 2024 RESULTS AND PROVIDES FISCAL 2025 GUIDANCE
DALLAS, Aug. 14, 2024 /PRNewswire/ -- Brinker International, Inc. (NYSE: EAT) today announced financial results for the fourth quarter ended June 26, 2024, and provided financial guidance fo...
08-14 18:45
快讯 | Ovid Therapeutics Inc - 预计将产生340万美元现金支出与重组有关
Ovid Therapeutics Inc - Expects to Incur $3.4 Mln Cash Expenditures Related to ...
08-13 20:05
快讯 | Ovid Therapeutics公司优化工作力量，裁撤17个职位。
Ovid Therapeutics Inc: Streamlined Its Workforce by Reducing 17 Positions
08-13 20:03
快讯 | ovid therapeutics 报告业务更新和2024年第二季度财务报告
Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Re...
08-13 20:00
快讯 | Ovid Therapeutics任命有经验的生物科技领袖和医生Amanda Banks博士为首席研发官
Ovid Therapeutics Appoints DR. Amanda Banks, Experienced Biotech Leader & P...
08-08 20:00
